In This Article:
As U.S. markets experience a slight pullback following recent record highs, investors are keenly watching how upcoming inflation data might influence Federal Reserve decisions. Amidst this backdrop, identifying stocks trading below their estimated value can offer potential opportunities for investors seeking to capitalize on market fluctuations and economic indicators.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
Name | Current Price | Fair Value (Est) | Discount (Est) |
NBT Bancorp (NasdaqGS:NBTB) | $50.26 | $99.93 | 49.7% |
UMB Financial (NasdaqGS:UMBF) | $123.67 | $243.25 | 49.2% |
Hims & Hers Health (NYSE:HIMS) | $32.63 | $64.70 | 49.6% |
West Bancorporation (NasdaqGS:WTBA) | $23.32 | $46.38 | 49.7% |
Business First Bancshares (NasdaqGS:BFST) | $28.19 | $54.93 | 48.7% |
Equity Bancshares (NYSE:EQBK) | $47.26 | $92.07 | 48.7% |
U.S. Physical Therapy (NYSE:USPH) | $96.50 | $187.03 | 48.4% |
Vasta Platform (NasdaqGS:VSTA) | $2.18 | $4.31 | 49.4% |
First Advantage (NasdaqGS:FA) | $20.00 | $39.00 | 48.7% |
Marcus & Millichap (NYSE:MMI) | $41.51 | $81.04 | 48.8% |
Here we highlight a subset of our preferred stocks from the screener.
Open Lending
Overview: Open Lending Corporation offers lending enablement and risk analytics solutions to credit unions, regional banks, finance companies, and automaker captive finance companies in the United States, with a market cap of approximately $742.36 million.
Operations: The company generates revenue from its Internet Information Providers segment, amounting to $95.89 million.
Estimated Discount To Fair Value: 43.5%
Open Lending is trading at US$6.22, significantly below its estimated fair value of US$11.02, highlighting potential undervaluation based on cash flows. Despite a decline in recent earnings and profit margins, the company's earnings are projected to grow substantially at 71.5% annually over the next three years, outpacing the broader US market's growth rate. Recent strategic partnerships aim to enhance loan processing efficiency for near- and non-prime borrowers, potentially boosting future revenue streams amidst stabilizing vehicle registration trends.
-
The growth report we've compiled suggests that Open Lending's future prospects could be on the up.
-
Get an in-depth perspective on Open Lending's balance sheet by reading our health report here.
Mesa Laboratories
Overview: Mesa Laboratories, Inc. is a company that develops, designs, manufactures, sells, and services life sciences tools and quality control products globally with a market cap of $673.50 million.
Operations: The company's revenue segments include Clinical Genomics ($46.57 million), Calibration Solutions ($49.04 million), Biopharmaceutical Development ($45.49 million), and Sterilization and Disinfection Control ($87.28 million).